Elucidating the anti-fibrotic mechanisms of Abrus cantoniensis in hepatic fibrosis using network pharmacology and proteomics
Yang Zheng, Jiahui Wang, Liang Liang, Yaxuan Qin, Lei Wang, Huaye Xiao · 2025
Read Elucidating the anti-fibrotic mechanisms of Abrus cantoniensis in hepatic fibrosis using network pharmacology and proteomics by Yang Zheng, Jiahui Wang, Liang Liang, Yaxuan Qin, Lei Wang, Huaye Xiao (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12848311.txt.
Description
Yang Zheng and five co-authors published a 2025 study of how a traditional plant, Abrus cantoniensis, fights liver scarring in mice. They gave mice a chemical that scars the liver, then treated them with the plant and confirmed the benefit under the microscope. Lab analysis found 420 compounds in the plant. Computer network methods and protein screens each listed hundreds of possible targets in the body.
Where the two lists overlapped, four core targets stood out. Docking tests showed the plant compounds bind those targets tightly and stably, and tissue stains showed the targets' activity fell after treatment. The authors argue the plant works through those four targets at once. They present the work as support for developing the plant into a standardized herbal medicine.
Catalog record
| CREATOR | Yang Zheng, Jiahui Wang, Liang Liang, Yaxuan Qin, Lei Wang, Huaye Xiao |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |